|
Liver Transpl Surg 1998 Jul;4(4):320-327
Recurrent hepatitis C virus infection after liver transplantation:
immunohistochemical assessment of the viral antigen.
Vargas V, Krawczynski K, Castells L, Martinez N, Esteban J, Allende
H, Esteban R, Guardia J
Liver Unit, Hospital General Universitari Vall d'Hebron, Barcelona,
Spain.
BACKGROUND:
The value of immunohistochemical methods to identify hepatitis C virus antigen
(HCVAg) in liver tissue has not been established. We have evaluated the significance
of HCVAg expression in livers of patients with transplants and recurrent hepatitis
C virus (HCV) infection.
METHODS:
Forty-two liver biopsy specimens from 32 liver-transplant recipients with recurrent
HCV infection were tested for HCVAg using fluorescein isothiocyanate-labeled
polyclonal, polyreactive human immunoglobulin. Histologic assessment of liver
and quantitation of HCV RNA in sera were carried out in specimens obtained simultaneously
with biopsies.
RESULTS:
HCVAg was found in 33% of the liver specimens obtained during the first month
after transplantation and in all liver specimens obtained between 1 and 18 months
after transplantation. Amounts of the antigen were significantly greater in
specimens obtained more than 1 month after transplantation. A statistically
significant increase of the average HCV RNA level in serum was observed in samples
tested after the first month after the transplantation, and some decrease in
the HCV RNA level was found in those obtained between 6 and 18 months after
transplantation. Larger amounts of HCVAg were observed in specimens corresponding
to episodes of acute or chronic hepatitis than in those associated with minimal
parenchymal evidence of rejection.
CONCLUSIONS:
OBSERVATIONS of HCVAg expression in liver biopsy specimens indicated that the
presence of viral antigens in hepatocytes is a constant finding in specimens
obtained 1 month or longer after transplantation. Although large amounts of
HCVAg correlated with acute or chronic hepatitis, the nature of this association
with the development of pathologic changes remains to be established. Copyright
1998 W.B. Saunders Company.
PMID: 9649647, UI: 98315288
table Of Contents
|